STING通路刺激在年轻和老年小鼠中诱导与低一氧化氮及增强抗体滴度相关的差异活化先天免疫表型
该研究比较了TLR激动剂与环二核苷酸(CDN)对骨髓来源树突状细胞(BMDC)先天免疫活化特征的差异,并检测体内抗体应答。CDN刺激BMDC产生明显不同的一氧化氮(NO)和BAFF分泌模式,与年轻及老年小鼠中更快速、持久的疫苗抗体应答相关。结果表明疫苗佐剂靶向的先天免疫通路可关键影响接种后免疫应答结局。
要点
- CDN与TLR配体刺激BMDC的代谢和细胞因子分泌特征明显不同。
- CDN刺激降低NO产生并增加BAFF分泌。
- 该差异与年轻和老年小鼠中更快速持久的抗体应答相关。
核心结论
- 佐剂靶向的先天免疫通路可关键影响接种后免疫应答结局。
- CDN刺激抗原提呈细胞诱导的低NO、高BAFF活化表型与年轻和老年小鼠中增强的疫苗抗体应答相关。
研究设计与样本
- 研究比较TLR激动剂与环二核苷酸(CDN)诱导的先天免疫活化范围。
- 研究观察两者对骨髓来源树突状细胞(BMDC)活化特征(如代谢、细胞因子分泌)的影响。
- 研究检测体内抗体应答诱导的差异效应。
主要发现
- 与TLR配体相比,CDN刺激BMDC诱导明显不同的代谢结局。
- CDN刺激BMDC后一氧化氮(NO)和细胞因子BAFF的产生出现显著差异。
- 这些差异与年轻和老年小鼠中更快速、更持久的疫苗抗体应答相关。
临床怎么用
- 可考虑采用差异激活先天免疫机制的佐剂以生成稳健的单剂疫苗。
- CDN类佐剂策略可能对免疫弱势人群(如老年)的疫苗应答改善有潜在价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: One of the most concerning public health issues, related to vaccination and disease prevention, is the inability to induce durable immune responses following a single-dose immunization. In this regard, the nature of the inflammatory environment induced by vaccine adjuvants can negatively impact the resulting immune response. To address these concerns, new strategies to vaccine design are needed in order to improve the outcomes of immune responses, particularly in immunologically disadvantaged populations. METHODS: Comparisons of the scope of innate immune activation induced by TLR agonists versus cyclic dinucleotides (CDNs) was performed. Their effects on the activation characteristics (e.g., metabolism, cytokine secretion) of bone marrow derived dendritic cells (BMDCs) were studied. In addition, the differential effects on in vivo induction of antibody responses were measured. RESULTS: As compared to TLR ligands, the stimulation of BMDCs with CDNs induced distinctly different metabolic outcomes. Marked differences were observed in the production of nitric oxide (NO) and the cytokine BAFF. These distinct differences were correlated with improved (i.e., more rapid and persistent) vaccine antibody responses in both aged and young mice. CONCLUSIONS: Our results illustrate that the innate immune pathway targeted by adjuvants can critically impact the outcome of the immune response post-vaccination. Specifically, CDN stimulation of APCs induced an activation phenotype that was characterized by decreased innate effector molecule production (e.g., NO) and increased BAFF. This was attributed to the induction of an innate inflammatory environment that enabled the host to make the most of the existing B lymphocyte potential. The use of adjuvants that differentially engage mechanisms of innate immune activation would be particularly advantageous for the generation of robust, single dose vaccines. The results of this study demonstrated that CDNs induced differential innate activation and enhanced vaccine induced antibody responses in both young and aged mice.
引用
- Darling RJ, Senapati S, Kelly SM, et al. STING pathway stimulation results in a differentially activated innate immune phenotype associated with low nitric oxide and enhanced antibody titers in young and aged mice. Vaccine. 2019. PMID: 30987850. doi:10.1016/j.vaccine.2019.04.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。